Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Sensorion

< Previous 1 2 3 Next >
Sensorion Announces Its Participation in Upcoming Investor Conferences to be Held in November 2024
From Sensorion
Via Business Wire
Sensorion Announces its Participation in the 31st Annual Congress of the European Society of Gene and Cell Therapy and the Presentation of Several Posters on GJB2-GT
From Sensorion
Via Business Wire
Sensorion Announces Webconference for Retail Shareholders on October 10, 2024
From Sensorion
Via Business Wire
Sensorion Announces the Availability of its Half Year 2024 Report
From Sensorion
Via Business Wire
Sensorion Reports New Positive Clinical Results Presented at the World Congress of Audiology
From Sensorion
Via Business Wire
Sensorion Announces New Positive Clinical Data Across its Gene Therapy and Small Molecule Programs at the World Congress of Audiology in Paris
From Sensorion
Via Business Wire
Sensorion Reports 2024 First Half Results and Highlights Recent Updates
From Sensorion
Via Business Wire
Sensorion Announces Its Participation in the 59th Annual Inner Ear Biology Workshop
From Sensorion
Via Business Wire
Sensorion Announces its Participation in the World Congress of Audiology in September 2024 in Paris and will Lead a Symposium on Medical Advances in the Field of Hearing Loss
From Sensorion
Via Business Wire
Sensorion Announces its Participation in Stifel's Biotech Summer Summit
From Sensorion
Via Business Wire
Sensorion Announces Positive Recommendation From the Data Safety Monitoring Board (DSMB) Regarding the Continuation of NOTOXIS, its Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity
From Sensorion
Via Business Wire
Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss
From Sensorion
Via Business Wire
Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer
From Sensorion
Via Business Wire
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
From Sensorion
Via Business Wire
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
From Sensorion
Via Business Wire
Sensorion Announces its Participation in Upcoming Investor Conferences in June 2024
From Sensorion
Via Business Wire
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 29, 2024
From Sensorion
Via Business Wire
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
From Sensorion
Via Business Wire
Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference
From Sensorion
Via Business Wire
Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025
From Sensorion
Via Business Wire
Sensorion Announces the Availability of Its Letter to Shareholders
From Sensorion
Via Business Wire
Sensorion Announces its Participation in the Annual Bioprocessing Summit Europe
From Sensorion
Via Business Wire
Sensorion Announces the Availability of its Financial Report for 2023
From Sensorion
Via Business Wire
Sensorion Reports Full-Year 2023 Financial Results and Business Update
From Sensorion
Via Business Wire
Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation
From Sensorion
Via Business Wire
Sensorion Will Host a Webcast on March 14, 2024, to Announce its 2023 Annual Financial Results
From Sensorion
Via Business Wire
Sensorion Announces its Participation in the Leerink Partners Global Biopharma Conference
From Sensorion
Via Business Wire
Sensorion Announces a €50.5 Million Financing With Participation From New and Existing US and European Healthcare Specialist Investors
From Sensorion
Via Business Wire
Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation
From Sensorion
Via Business Wire
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 47th Annual Midwinter Meeting
From Sensorion
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS